Waldemar Halota

Department of Infectious Diseases and Hepatology

H指数:24

被引数:3,956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and predictors of HCV infection among hospitalized psychiatric patients in Poland

Frontiers in Psychiatry

IF3.2

2026-07-260

OAAI

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-09-018

OAAI

Rajewski, Pawel; Zarebska-Michaluk, Dorota; Janczewska, Ewa; Gietka, Andrzej; Mazur, Wlodzimierz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Dybowska, Dorota; Halota, Waldemar; Lorenc, Beata; Sitko, Marek; Garlicki, Aleksander; Berak, Hanna; Horban, Andrzej; Orlowska, Iwona; Simon, Krzysztof; Socha, Lukasz; Wawrzynowicz-Syczewska, Marta; Jaroszewicz, Jerzy; Deron, Zbigniew; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Krygier, Rafal; Piekarska, Anna; Laurans, Lukasz; Dobracki, Witold; Bialkowska, Jolanta; Tronina, Olga; Wietlicka-Piszcz, Magdalena; Pawlowska, Malgorzata; Flisiak, Robert

HCV Genotype Has No Influence on the Incidence of Diabetes-EpiTer Multicentre Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-01-134

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-07-2517

OAAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Parfieniuk-Kowerda, Anna; Janczewska, Ewa; Dybowska, Dorota; Pawlowska, Malgorzata; Halota, Waldemar; Mazur, Wlodzimierz; Lorenc, Beata; Janocha-Litwin, Justyna; Simon, Krzysztof; Piekarska, Anna; Berak, Hanna; Klapaczynski, Jakub; Stepien, Piotr; Sobala-Szczygiel, Barbara; Citko, Jolanta; Socha, Lukasz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Dobracka, Beata; Krygier, Rafal; Bialkowska-Warzecha, Jolanta; Laurans, Lukasz; Flisiak, Robert

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2021-05-1411

OAAI

Janczewska, Ewa; Kolek, Mateusz Franciszek; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Zarebska-Michaluk, Dorota; Buczynska, Iwona; Dybowska, Dorota; Czau-Anderzejuk, Agnieszka; Berak, Hanna; Krygier, Rafal; Jaroszewicz, Jerzy; Citko, Jolanta; Piekarska, Anna; Dobracka, Beata; Socha, Lukasz; Deron, Zbigniew; Laurans, Lukasz; Bialkowska-Warzecha, Jolanta; Tronina, Olga; Adamek, Brygida; Tomasiewicz, Krzysztof; Simon, Krzysztof; Pawlowska, Malgorzata; Halota, Waldemar; Flisiak, Robert

Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study

肝硬化和肝功能失代偿史患者直接抗病毒药物的真实世界有效性和安全性: Epi-Ter2研究

LIVER INTERNATIONAL

IF5.2

2021-03-1818

PREAI

Berkan-Kawinska, Aleksandra; Piekarska, Anna; Janczewska, Ewa; Lorenc, Beata; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Berak, Hanna; Horban, Andrzej; Zarebska-Michaluk, Dorota; Pabjan, Pawel; Buczynska, Iwona; Pazgan-Simon, Monika; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Klapaczynski, Jakub; Mazur, Wlodzimierz; Czau(z) over dot-Andrzejuk, Agnieszka; Socha, Lukasz; Laurans, Lukasz; Garlicki, Aleksander; Sitko, Marek; Jaroszewicz, Jerzy; Citko, Jolanta; Dobracka, Beata; Krygier, Rafal; Bialkowska-Warzecha, Jolanta; Tronina, Olga; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Flisiak, Robert

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?

在现实世界中，格列卡普雷韦/皮布伦他韦的8周治疗方案是否足以满足所有感染丙型肝炎病毒的患者？

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2020-11-2311

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Pabjan, Pawel; Lapinski, Tadeusz W.; Mazur, Wlodzimierz; Krygier, Rafal; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Janczewska, Ewa; Buczynska, Iwona; Simon, Krzysztof; Dobracka, Beata; Citko, Jolanta; Laurans, Lukasz; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Piekarska, Anna; Sitko, Marek; Bialkowska-Warzecha, Jolanta; Klapaczynski, Jakub; Sobala-Szczygiel, Barbara; Horban, Andrzej; Berak, Hanna; Deron, Zbigniew; Lorenc, Beata; Socha, Lukasz; Tronina, Olga; Flisiak, Robert

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2020-06-2714

PREAI

Jaroszewicz, Jerzy; Pawlowska, Malgorzata; Simon, Krzysztof; Zarebska-Michaluk, Dorota; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Janczewska, Ewa; Paluch, Katarzyna; Dybowska, Dorota; Buczynska, Iwona; Czauz-Andrzejuk, Agnieszka; Berak, Hanna; Krygier, Rafal; Piasecki, Maciej; Dobracka, Beata; Citko, Jolanta; Piekarska, Anna; Socha, Lukasz; Deron, Zbigniew; Tronina, Olga; Laurans, Lukasz; Bialkowska, Jolanta; Tomasiewicz, Krzysztof; Halota, Waldemar; Flisiak, Robert

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ

IF4.7

2020-02-0724

Flisiak, Robert; Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Lorenc, Beata; Klapaczynski, Jakub; Tudrujek-Zdunek, Magdalena; Sitko, Marek; Mazur, Wlodzimierz; Janczewska, Ewa; Pabjan, Pawel; Dybowska, Dorota; Buczynska, Iwona; Czauz-Andrzejuk, Agnieszka; Belica-Wdowik, Teresa; Berak, Hanna; Krygier, Rafal; Piasecki, Maciej; Dobracka, Beata; Citko, Jolanta; Piekarska, Anna; Socha, Lukasz; Deron, Zbigniew; Tronina, Olga; Laurans, Lukasz; Bialkowska, Jolanta; Tomasiewicz, Krzysztof; Halota, Waldemar; Simon, Krzysztof; Pawlowska, Malgorzata

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously difficult to treat patients infected with hepatitis C virus genotype 1 and 4

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2020-01-169

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Buczynska, Iwona; Simon, Krzysztof; Lorenc, Beata; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Garlicki, Aleksander; Janczewska, Ewa; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Pabjan, Pawel; Mazur, Wlodzimierz; Czauz-Andrzejuk, Agnieszka; Berak, Hanna; Horban, Andrzej; Socha, Lukasz; Klapaczynski, Jakub; Piekarska, Anna; Blaszkowska, Maria; Belica-Wdowik, Teresa; Dobracka, Beata; Tronina, Olga; Deron, Zbigniew; Bialkowska-Warzecha, Jolanta; Laurans, Lukasz; Flisiak, Robert

Efficacy of 8-versus 12-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-week regimen in a real-world setting

在现实环境中，符合8周治疗方案的慢性丙型肝炎患者中，ledipasvir/sofosbuvir治疗8周与12周的疗效

ARCHIVES OF MEDICAL SCIENCE

IF3.3

2019-07-113

OAAI

Zarebska-Michaluk, Dorota; Piekarska, Anna; Jaroszewicz, Jerzy; Klapaczynski, Jakub; Sitko, Marek; Tudrujek-Zdunek, Magdalena; Tomasiewicz, Krzysztof; Belica-Wdowik, Teresa; Pabjan, Pawel; Lorenc, Beata; Czauz-Andrzejuk, Agnieszka; Tronina, Olga; Krygier, Rafal; Dobracki, Witold; Buczynska, Iwona; Simon, Krzysztof A.; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Citko, Jolanta; Laurans, Lukasz; Mazur, Wlodzimierz; Janczewska, Ewa; Socha, Lukasz; Deron, Zbigniew; Berak, Hanna; Flisiak, Robert

Comparative effectiveness of 8 versus 12 weeks of ombitasvir/paritaprevir/ritonavir and dasabuvir in treatment-naive patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Jakub, Klapaczynski; Mazur, Wlodzimierz; Krygier, Rafal; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Janczewska, Ewa; Pabjan, Pawel; Dobracka, Beata; Lorenc, Beata; Tudrujek, Magdalena; Tomasiewicz, Krzysztof; Sitko, Marek; Garlicki, Aleksander; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Laurans, Lukasz; Zbigniew, Deron; Orlowska, Iwona; Krzysztof, Simon; Bialkowska-Warzecha, Jolanta; Olga, Tronina; Flisiak, Robert

Effectiveness and safety of DAA-based treatment of hepatitis C patients with severe and end stage chronic kidney diseases-EpiTer-2 database analysis

JOURNAL OF HEPATOLOGY

IF33

2019-04-010

PREAI

Low risk of HBV reactivation in a large European cohort of HBV/HCV coinfected patients treated with DAA

JOURNAL OF HEPATOLOGY

IF33

2019-04-011

PREAI

Jaroszewicz, Jerzy; Piasecki, Maciej; Lorenc, Beata; Buczynska, Iwona; Krzysztof, Simon; Zarebska-Michaluk, Dorota; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Garlicki, Aleksander; Belica-Wdowik, Teresa; Janczewska, Ewa; Dobracka, Beata; Tudrujek, Magdalena; Tomasiewicz, Krzysztof; Berak, Hanna; Mazur, Wlodzimierz; Olga, Tronina; Jakub, Klapaczynski; Krygier, Rafal; Czauz-Andrzejuk, Agnieszka; Citko, Jolanta; Socha, Lukasz; Piekarska, Anna; Zbigniew, Deron; Bialkowska-Warzecha, Jolanta; Flisiak, Robert

Efficacy of 8 versus 12-weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C patients eligible for 8-weeks regimen in real world setting

JOURNAL OF HEPATOLOGY

IF33

2019-04-012

PREAI

Zarebska-Michaluk, Dorota; Jaroszewicz, Jerzy; Jakub, Klapaczynski; Sitko, Marek; Garlicki, Aleksander; Tudrujek, Magdalena; Tomasiewicz, Krzysztof; Belica-Wdowik, Teresa; Baka-Cwierz, Barbara; Pabjan, Pawel; Lorenc, Beata; Czauz-Andrzejuk, Agnieszka; Olga, Tronina; Krygier, Rafal; Dobracka, Beata; Orlowska, Iwona; Krzysztof, Simon; Dybowska, Dorota; Halota, Waldemar; Pawlowska, Malgorzata; Citko, Jolanta; Laurans, Lukasz; Mazur, Wlodzimierz; Piekarska, Anna; Janczewska, Ewa; Socha, Lukasz; Wawrzynowicz-Syczewska, Marta; Zbigniew, Deron; Berak, Hanna; Andrzej, Horban; Flisiak, Robert

The efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

BMC INFECTIOUS DISEASES

IF3

2018-11-162

OAAI

Janczewska, Ewa; Zarebska-Michaluk, Dorota; Berak, Hanna; Piekarska, Anna; Gietka, Andrzej; Dybowska, Dorota; Mazur, Wlodzimierz; Belica-Wdowik, Teresa; Dobracki, Witold; Tudrujek-Zdunek, Magdalena; Deron, Zbigniew; Buczynska, Iwona; Sitko, Marek; Czauz-Andrzejuk, Agnieszka; Lorenc, Beata; Bialkowska-Warzecha, Jolanta; Citko, Jolanta; Laurans, Lukasz; Jaroszewicz, Jerzy; Socha, Lukasz; Tronina, Olga; Adamek, Brygida; Horban, Andrzej; Halota, Waldemar; Baka-Cwierz, Barbara; Tomasiewicz, Krzysztof; Simon, Krzysztof; Garlicki, Aleksander; Wawrzynowicz-Syczewska, Marta; Flisiak, Robert

The efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir and ledipasvir/sofosbuvir is similar in patients who failed interferon-based treatment with first generation protease inhibitors

JOURNAL OF HEPATOLOGY

IF33

2018-04-010

PREAI

Janczewska, E.; Flisiak, R.; Zarebska-Michaluk, D.; Arkadiusz, P.; Staniaszek, A.; Gietka, A.; Mazur, W.; Tudrujek, M.; Tomasiewicz, K.; Belica-Wdowik, T.; Baka-Cwierz, B.; Dybowska, D.; Halota, W.; Lorenc, B.; Sitko, M.; Garlicki, A.; Berak, H.; Andrzej, H.; Orlowska, I.; Krzysztof, S.; Socha, L.; Wawrzynowicz-Syczewska, M.; Jaroszewicz, J.; Zbigniew, D.; Czauz-Andrzejuk, A.; Citko, J.; Krygier, R.; Piekarska, A.; Laurans, L.; Dobracka, B.; Bialkowska-Warzecha, J.; Olga, T.; Pawlowska, M.

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial

JOURNAL OF HEPATOLOGY

IF33

2016-12-0142

PREAI

Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2016-09-0994

OAAI

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus

WORLD JOURNAL OF GASTROENTEROLOGY